Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Generalized Anxiety Disorder × Probiotics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 5 Breast Neoplasms 5 Stomach Neoplasms 3 Neoplasms 3 Uterine Cervical Neoplasms 2 Mucositis 2 Malnutrition 2 Lung Neoplasms 2 Diarrhea 2 Chalazion 2 Carcinoma, Hepatocellular 2 Thyroid Neoplasms 1 Squamous Intraepithelial Lesions 1 Smoldering Multiple Myeloma 1 Radiation Injuries 1 Psychological Well-Being 1 Psoriasis Vulgaris 1 Polycystic Ovary Syndrome 1 Periampullary Carcinoma Nos 1 Pelvic Neoplasms 1 Pelvic Inflammatory Disease 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 Muscle Invasive Bladder Cancer (MIBC) 1 Multiple Myeloma 1 Motor Activity 1 Monoclonal Gammopathy of Undetermined Significance 1 Liver Cirrhosis 1 Limited Stage Small Cell Lung Cancer 1

Interventions

Waiting Lists 1 Probiotics 1 Early Detection of Cancer 1 Cognitive Behavioral Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04784182 2023-08-24

ABBCS

Auburn University

Phase NA Terminated

3 enrolled 10 charts

Generalized Anxiety Disorder

Data powered by HemOnc (CC BY 4.0) Colophon ⚡